Zogenix gains on first EU approval for Sumavel

Zogenix Inc. (NASDAQ:ZGNX) rose $0.64 (16%) to $4.64 on Thursday after the Danish Medicines Agency approved an MAA from partner Desitin Arzneimittel GmbH (Hamburg, Germany) for Sumavel DosePro sumatri...